Beyond Women's Health: Long-Term Human Papillomavirus–Related Cancer Trends in Norway - Takeaways - MDSpire

Beyond Women's Health: Long-Term Human Papillomavirus–Related Cancer Trends in Norway

  • By

  • Thea E Hetland Falkenthal

  • Ståle Nygård

  • Mari Nygård

  • July 9, 2025

  • 0 min

Share

  • 1

    HPV-attributable cancer incidence in Norway is rising, particularly among men, with oropharyngeal SCC increasing at 4.5% annually.

  • 2

    Cervical cancer incidence in women has decreased by 6% annually from 2018 to 2023, following the implementation of HPV testing.

  • 3

    The overall burden of HPV-related cancers beyond cervical cancer is increasing in Norway, projected to rise until 2038.

  • 4

    HPV vaccination programs were initiated in Norway for girls in 2009 and boys in 2018, aiming to reduce HPV-attributable cancers.

  • 5

    No early detection programs exist for non-cervical HPV-related cancers in Norway, despite rising incidence rates.

Original Source(s)

Beyond Women's Health: Long-Term Human Papillomavirus–Related Cancer Trends in Norway

  • by Thea E Hetland Falkenthal, Ståle Nygård, Mari Nygård

  • July 9, 2025

Related Content

Progress and prospects for herpesvirus vaccination using gB antigens

The Relationship Between Media Exposure and Attitudes, Intentions, and Hesitancy Regarding Vaccines: A Systematic Review

Hospitals are silencing doctors online, and it’s fueling the health misinformation crisis